
http://www.exelixis.com
Exelixis, Inc. Company Intro
We drive to deliver results and new medicines to treat and defeat cancer, giving patients hope for the future. Cancer is our cause.
Industry
Healthcare
Exelixis, Inc. Headquaters
1851 Harbor Bay Parkway
Alameda,94502
United States
Exelixis, Inc. Share price
16 Apr 2021 01:38 GMT
$24.29
0.24 (1.0 %)
Exelixis, Inc. Market cap
$7.472 B
WMC RANKING
2021
Exelixis, Inc. # 12
BiotechnologyLatest Exelixis, Inc. News
30 Mar 2021
Exelixis Announces Enrollment Completion in Phase 3 ...
BUSINESS WIRE)-- Exelixis, Inc. (Nasdaq: EXEL) today announced that COSMIC-313, the phase 3 pivotal trial evaluating the combination of cabozantinib ...
30 Mar 2021
Latest Industry News: Neuroendocrine Tumor Treatment ...
Exelixis, Inc., Advanced Accelerator Applications, Dauntless Pharmaceuticals, ... based on the key factors such as company size, market share, market growth, ...
30 Mar 2021
Steroids Market Size, Demand, Cost Structures, Market Status ...
The Major Players Covered in this Report: Mission Pharmacal Company, ... Tumor Treatment Market Regional Analysis By Product Type till 2026| Exelixis, Inc., ...
WMC Market Score
WMC Market to Revenue Score
Exelixis, Inc. Market Financials
Revenue, Expenses, Profit
Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
Exelixis, Inc. | USD | $967,775 | $565,208 | $321,012 | $74,720B | 12 |
Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $529,920B | 1 |
Vertex Pharmaceuticals Incorporated | USD | $6,205,683 | $2,599,993 | $2,711,647 | $572,250B | 2 |
Alexion Pharmaceuticals, Inc. | USD | $6,069,900 | $2,656,500 | $603,400 | $348,030B | 3 |
Incyte Corporation | USD | $2,229,409 | $1,622,822 | $446,906 | $182,910B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Exelixis, Inc. Social Followers vs Top 4 Industry Competitors
Exelixis, Inc. Post vs Top 4 Industry Competitors
Exelixis, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Exelixis, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Exelixis, Inc. WMC Market Score Calculations
Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
Exelixis, Inc. | 10.47 | 12.81 | 0.37 | 0 | 0 | 0 | 5.07 |
Regeneron Pharmaceuticals, Inc. | 100 | 23.95 | 9.71 | 100 | 0 | 0 | 51.39 |
Vertex Pharmaceuticals Incorporated | 67.14 | 35.09 | 2.77 | 86 | 0 | 0 | 47.55 |
Alexion Pharmaceuticals, Inc. | 65.67 | 100 | 100 | 60 | 0 | 0 | 100 |
Incyte Corporation | 24.12 | 4.95 | 0.25 | 2 | 0 | 0 | 2.93 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge